Dr. Watson was one of three recipients of the 1962 Nobel Prize in Physiology or Medicine for decoding the genetic blueprint for life.

Learn more about whether BioMarin Pharmaceutical Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio’s ATACR and SEECR formats, ...

James Dewey Watson, Nobel Prize winner and “semi-professional loose cannon” whose racist views made him a scientific pariah ...

On a foggy Saturday morning in 1953, a tall, skinny 24-year-old man fiddled with shapes he had cut out of cardboard. They ...

So, what are retrons? They’re bacterial immune systems that save the bacterial herd by culling individual bacteria infected ...

Often celebrated as a pioneer of genetics alongside Francis Crick, racist and sexist remarks tarnished his reputation in ...

The Age of AI will rely on massive volumes of data that can be easily stored and retrieved—and bioscience may have an ingenious solution. A scientist examines a DNA (deoxyribonucleic acid) profile on ...

Genetic engineers can design and assemble sophisticated gene circuits to program cells with new functions, but important ...

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi ...

Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic imneskibart (AU-007), today presented promising ...